A research on endometrial cancer showed that increased BORIS mRNA expression level associates with cancer progression and poor survival, so that all the clinically established markers for aggressive endometrial carcinoma including high age, non-endometroid histology, high grade, and hormone receptor loss were significantly associated with high BORIS mRNA levels [32]. Here, CTCFL is linked to endometrial carcinoma.